South Korea · Delayed Price · Currency is KRW Genesem Statistics
Total Valuation
Genesem has a market cap or net worth of KRW 78.13 billion. The enterprise value is 95.33 billion.
| Market Cap | 78.13B |
| Enterprise Value | 95.33B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
Genesem has 13.15 million shares outstanding. The number of shares has decreased by -1.05% in one year.
| Current Share Class | 13.15M |
| Shares Outstanding | 13.15M |
| Shares Change (YoY) | -1.05% |
| Shares Change (QoQ) | +0.89% |
| Owned by Insiders (%) | 44.53% |
| Owned by Institutions (%) | n/a |
| Float | 7.30M |
Valuation Ratios
The trailing PE ratio is 415.61.
| PE Ratio | 415.61 |
| Forward PE | n/a |
| PS Ratio | 1.31 |
| PB Ratio | 1.59 |
| P/TBV Ratio | 1.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 507.10 |
| EV / Sales | 1.59 |
| EV / EBITDA | 42.33 |
| EV / EBIT | 92.02 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.44.
| Current Ratio | 1.38 |
| Quick Ratio | 0.57 |
| Debt / Equity | 0.44 |
| Debt / EBITDA | 8.23 |
| Debt / FCF | -1.42 |
| Interest Coverage | 2.32 |
Financial Efficiency
Return on equity (ROE) is 0.41% and return on invested capital (ROIC) is 0.23%.
| Return on Equity (ROE) | 0.41% |
| Return on Assets (ROA) | 0.94% |
| Return on Invested Capital (ROIC) | 0.23% |
| Return on Capital Employed (ROCE) | 2.49% |
| Weighted Average Cost of Capital (WACC) | 9.02% |
| Revenue Per Employee | 380.74M |
| Profits Per Employee | 1.20M |
| Employee Count | 157 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 1.50 |
Taxes
In the past 12 months, Genesem has paid 1.72 billion in taxes.
| Income Tax | 1.72B |
| Effective Tax Rate | 89.60% |
Stock Price Statistics
The stock price has increased by +23.52% in the last 52 weeks. The beta is 1.30, so Genesem's price volatility has been higher than the market average.
| Beta (5Y) | 1.30 |
| 52-Week Price Change | +23.52% |
| 50-Day Moving Average | 5,491.10 |
| 200-Day Moving Average | 5,797.36 |
| Relative Strength Index (RSI) | 56.06 |
| Average Volume (20 Days) | 221,610 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genesem had revenue of KRW 59.78 billion and earned 187.99 million in profits. Earnings per share was 14.39.
| Revenue | 59.78B |
| Gross Profit | 23.28B |
| Operating Income | 1.38B |
| Pretax Income | 1.93B |
| Net Income | 187.99M |
| EBITDA | 2.60B |
| EBIT | 1.38B |
| Earnings Per Share (EPS) | 14.39 |
Balance Sheet
The company has 4.10 billion in cash and 21.41 billion in debt, with a net cash position of -17.31 billion or -1,316.35 per share.
| Cash & Cash Equivalents | 4.10B |
| Total Debt | 21.41B |
| Net Cash | -17.31B |
| Net Cash Per Share | -1,316.35 |
| Equity (Book Value) | 49.18B |
| Book Value Per Share | 3,756.39 |
| Working Capital | 15.92B |
Cash Flow
In the last 12 months, operating cash flow was -13.25 billion and capital expenditures -1.78 billion, giving a free cash flow of -15.03 billion.
| Operating Cash Flow | -13.25B |
| Capital Expenditures | -1.78B |
| Depreciation & Amortization | 1.22B |
| Net Borrowing | 1.79B |
| Free Cash Flow | -15.03B |
| FCF Per Share | -1,142.69 |
Margins
Gross margin is 38.94%, with operating and profit margins of 2.32% and 0.31%.
| Gross Margin | 38.94% |
| Operating Margin | 2.32% |
| Pretax Margin | 3.22% |
| Profit Margin | 0.31% |
| EBITDA Margin | 4.35% |
| EBIT Margin | 2.32% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.80%.
| Dividend Per Share | 50.00 |
| Dividend Yield | 0.80% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 349.84% |
| Buyback Yield | 1.05% |
| Shareholder Yield | 1.85% |
| Earnings Yield | 0.24% |
| FCF Yield | -19.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 24, 2025. It was a forward split with a ratio of 1.5.
| Last Split Date | Nov 24, 2025 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
Genesem has an Altman Z-Score of 2.1 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.1 |
| Piotroski F-Score | 5 |